ANSBERT GADICKE Insider Trading for April 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANSBERT GADICKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ANSBERT GADICKE for April 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.54 | 21,781 | 490,944 | 6,889,977 | 6.9 M to 6.9 M (-0.32 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.02 | 45,511 | 1,002,152 | 6,911,758 | 7 M to 6.9 M (-0.65 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.01 | 36,803 | 810,034 | 6,957,269 | 7 M to 7 M (-0.53 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 21.64 | 14,219 | 307,699 | 6,994,072 | 7 M to 7 M (-0.20 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 21.26 | 8,328 | 177,053 | 7,008,291 | 7 M to 7 M (-0.12 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.99 | 3,501 | 73,486 | 7,016,619 | 7 M to 7 M (-0.05 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.09 | 834 | 15,921 | 7,029,092 | 7 M to 7 M (-0.01 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 18.70 | 21,415 | 400,461 | 7,029,926 | 7.1 M to 7 M (-0.30 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.08 | 100 | 2,008 | 7,051,341 | 7.1 M to 7.1 M (0.00 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.29 | 9,956 | 192,051 | 7,051,441 | 7.1 M to 7.1 M (-0.14 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.56 | 300 | 6,168 | 7,061,397 | 7.1 M to 7.1 M (0.00 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.82 | 5,547 | 109,942 | 7,061,697 | 7.1 M to 7.1 M (-0.08 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.49 | 8,696 | 178,181 | 7,067,244 | 7.1 M to 7.1 M (-0.12 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.83 | 12,806 | 266,749 | 7,075,940 | 7.1 M to 7.1 M (-0.18 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.06 | 1,000 | 20,060 | 7,088,746 | 7.1 M to 7.1 M (-0.01 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.08 | 2,362 | 47,429 | 7,089,746 | 7.1 M to 7.1 M (-0.03 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.35 | 13,692 | 264,940 | 7,092,108 | 7.1 M to 7.1 M (-0.19 %) |
Apr 13 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 29.99 | 200 | 5,998 | 6,004,368 | 6 M to 6 M (0.00 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.68 | 400 | 9,072 | 7,105,800 | 7.1 M to 7.1 M (-0.01 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 21.52 | 6,700 | 144,184 | 7,106,200 | 7.1 M to 7.1 M (-0.09 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.72 | 13,528 | 280,300 | 7,112,900 | 7.1 M to 7.1 M (-0.19 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 23.67 | 10,300 | 243,801 | 7,126,428 | 7.1 M to 7.1 M (-0.14 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 31.01 | 414 | 12,838 | 6,004,568 | 6 M to 6 M (-0.01 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 30.51 | 31,890 | 972,964 | 6,004,982 | 6 M to 6 M (-0.53 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 31.01 | 414 | 12,838 | 6,004,568 | 6 M to 6 M (-0.01 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | J | 0.00 | 15,670 | 0 | 6,036,872 | 6.1 M to 6 M (-0.26 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 30.51 | 31,890 | 972,964 | 6,004,982 | 6 M to 6 M (-0.53 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 33.84 | 1,300 | 43,992 | 6,052,542 | 6.1 M to 6.1 M (-0.02 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | J | 0.00 | 15,670 | 0 | 6,036,872 | 6.1 M to 6 M (-0.26 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.84 | 3,083 | 101,246 | 6,053,842 | 6.1 M to 6.1 M (-0.05 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 33.84 | 1,300 | 43,992 | 6,052,542 | 6.1 M to 6.1 M (-0.02 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.07 | 5,295 | 169,811 | 6,056,925 | 6.1 M to 6.1 M (-0.09 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.84 | 3,083 | 101,246 | 6,053,842 | 6.1 M to 6.1 M (-0.05 %) |
Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.07 | 5,295 | 169,811 | 6,056,925 | 6.1 M to 6.1 M (-0.09 %) |